HCPCS Level II code M0201 designates in-home administration of pneumococcal, influenza, hepatitis B, and/or COVID-19 vaccines, reported once per individual home per date of service. This code captures vaccination efforts delivered directly in patients' residences, supporting public health initiatives to improve vaccine access for homebound or mobility-limited populations. Nationally, in-home vaccine administration is a component of community-based preventive care strategies and can affect immunization coverage and service delivery patterns across payers.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical and billing intent, the typical setting for use, and which payers are relevant to coverage and claims submission. The publication also outlines common modifiers associated with in-home services (listed separately) and notes where input data is not provided.

This piece provides context for billing teams, practice managers, and policy analysts seeking to understand how M0201 is used to document home-based vaccine administration, the service type it represents, and the typical site of service. Data not available in the input is noted where applicable; the focus remains on clear description, payer scope, and operational understanding of the code for national audiences.